LENZ Therapeutics, Inc. ( LENZ) - Stock Earnings
LENZ Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026, midnight | — / — | — | — / — | — |
LENZ Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -16.7 million USD | 12.5 million USD |
| 2025Q4 | -35.9 million USD | 1.6 million USD |
| 2026Q1 | -41.5 million USD | 1.9 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LENZ Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -70.0 million USD | — USD |
| 2024 | -49.8 million USD | — USD |
| 2025 | -82.1 million USD | 19.1 million USD |
| 2026 Est. | — | — |
LENZ
Price: $5.48
52 week price:
Dividend Yield: 122.41%
Earnings Per Share: -3.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 184.7 million